<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sipsas, Nikolaos V</style></author><author><style face="normal" font="default" size="100%">Papaparaskevas, Joseph</style></author><author><style face="normal" font="default" size="100%">Stefanou, Ioanna</style></author><author><style face="normal" font="default" size="100%">Kalatzis, Konstantinos</style></author><author><style face="normal" font="default" size="100%">Vlachoyiannopoulos, Panayiotis</style></author><author><style face="normal" font="default" size="100%">Avlamis, Athina</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Septic arthritis due to Roseomonas mucosa in a rheumatoid arthritis patient receiving infliximab therapy.</style></title><secondary-title><style face="normal" font="default" size="100%">Diagn Microbiol Infect Dis</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Diagn. Microbiol. Infect. Dis.</style></alt-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Adult</style></keyword><keyword><style  face="normal" font="default" size="100%">Antibodies, Monoclonal</style></keyword><keyword><style  face="normal" font="default" size="100%">Antirheumatic Agents</style></keyword><keyword><style  face="normal" font="default" size="100%">Arthritis, Infectious</style></keyword><keyword><style  face="normal" font="default" size="100%">Gram-Negative Bacterial Infections</style></keyword><keyword><style  face="normal" font="default" size="100%">Humans</style></keyword><keyword><style  face="normal" font="default" size="100%">Immunocompromised Host</style></keyword><keyword><style  face="normal" font="default" size="100%">Male</style></keyword><keyword><style  face="normal" font="default" size="100%">Methylobacteriaceae</style></keyword><keyword><style  face="normal" font="default" size="100%">Molecular Sequence Data</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2006</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2006 Aug</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">55</style></volume><pages><style face="normal" font="default" size="100%">343-5</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">We report a case of septic arthritis due to Roseomonas mucosa in a rheumatoid arthritis patient receiving infliximab therapy. This is the first report of septic arthritis due to R. mucosa, and infliximab therapy might be a predisposing factor because this infection was never reported in the pre-anti-tumor necrosis factor alpha therapy period.</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><custom1><style face="normal" font="default" size="100%">http://www.ncbi.nlm.nih.gov/pubmed/16626905?dopt=Abstract</style></custom1></record></records></xml>